UK Innovation & Science Seed Fund

iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Ikarovec is a gene therapy company focused on developing early-stage treatments for common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, working on therapies that also target dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By advancing these innovative treatments, Ikarovec seeks to provide effective solutions for patients, helping to restore sight and prevent blindness.

Lineat is a manufacturer specializing in fiber tape products, particularly focusing on carbon fiber tapes produced through aligned formable fiber technology. This innovative approach allows for the creation of aligned discontinuous fiber tapes that demonstrate mechanical performance comparable to traditional continuous fiber composites. By simplifying the composite manufacturing process, Lineat enhances formability and streamlines both manual and automated operations. Additionally, the company has implemented a closed-loop water circulation system aimed at improving lifecycle assessment (LCA), reflecting its commitment to sustainability in production practices.

Antiverse is an innovative biotechnology company specializing in accelerating drug development through its proprietary platform. This platform combines structural biology, machine learning, and medicine to facilitate quicker and more cost-effective breakthroughs in antibody discovery.

Aquark Technologies specializes in the development of compact cold atom systems aimed at advancing quantum applications, such as atomic clocks, sensors, and navigation systems. The company has pioneered a method to miniaturize these systems using innovative laser geometry, building on over a decade of proprietary research conducted at the University of Southampton. By creating plug-and-play cold-atom quantum devices that are comparable in size to a matchbox, Aquark Technologies offers clients portable and scalable solutions, facilitating the integration of quantum technologies into everyday life and positioning itself at the forefront of the next generation of quantum sensing and computing.

Solasta Bio develops environmentally friendly biological pesticides and insect control products. Its portfolio includes neuropeptide-based solutions that effectively manage resistant pests, enabling farmers to enhance crop production sustainably.

HonuWorx is a technology company specializing in autonomous subsea robotics. It develops unmanned marine systems designed to deploy and control robots for offshore work, reducing reliance on large manned vessels. The company's edge-cloud architected software platform enables real-time data sharing, collaboration, supervision, and control of robotic systems beyond line-of-sight. This technology lowers operational expenses and environmental impact by minimizing travel requirements offshore, facilitating sustainable commercialization of ocean resources.

Adamo Foods is a UK-based company developing plant-based whole-cut meats using proprietary fermentation technology combined with mycelium.

Wave Photonics is a company based in Cambridge, UK, focused on enhancing the design and integration of integrated photonics products. It develops a platform that utilizes computational techniques to optimize product designs and streamline the supply chain. This platform offers a software tool that predicts the performance and variability of components based on specific fabrication processes, along with an optimizer to create a library of foundry-specific components. By facilitating the development and mass production of integrated photonics technologies, Wave Photonics aims to improve efficiency and reduce redundancy for businesses in the sector.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, founded in 2015 as a spin‑out from the STFC Rutherford Appleton Laboratory. It develops high‑performance gas‑sensing products that use laser dispersion, tunable laser absorption, and isotope‑ratio techniques to provide real‑time, in‑situ monitoring of trace gases and isotopologues. The instruments are applied in space exploration, planetary landers, environmental monitoring, atmospheric emissions, geochemistry, medical diagnostics, and oil‑and‑gas exploration and production. The company’s cloud‑connected platform delivers autonomous, continuous measurements in all weather conditions, enabling detection, localisation, and quantification of emissions to support net‑zero targets and operational optimisation.

Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

Presymptom Health is a medical technology company dedicated to advancing healthcare through the development of pre-symptomatic diagnostic tests and clinical decision support algorithms. The company focuses on creating innovative blood tests designed to detect illnesses at an early stage, particularly aiming to predict the onset of sepsis up to three days before symptoms manifest. By enabling earlier intervention, Presymptom Health seeks to improve critical care outcomes and enhance patient management, ultimately contributing to better survival rates and healthcare efficiency.

ExactTrak specializes in cybersecurity software designed to protect mobile data. Its solutions are embedded into hardware like USB drives and laptops, offering managed services to prevent data loss and ensure compliance.

HutanBio is a biotechnology company focused on producing sustainable biofuels derived from algae. The firm specializes in developing HBx bio-oil, which is characterized by its high energy density, low carbon footprint, and absence of sulfur. HutanBio's innovative approach allows for scalable production through its algal farms, catering to various sectors, including marine, land, and aviation. By providing a drop-in replacement fuel, the company enables its clients to reduce emissions and comply with environmental regulations, contributing to a more sustainable energy landscape.

Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

MitoRx Therapeutics is a biotechnology company focused on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company specializes in creating mitochondrial-protective treatments for a range of conditions, including neuromuscular disorders, metabolic diseases, and dementia. By targeting the underlying mitochondrial issues associated with these challenging diseases, MitoRx Therapeutics seeks to enable healthcare professionals to halt the progression of conditions such as dystrophy and neurodegeneration. In addition to its internal research on rare indications, the company also collaborates on broader health issues, positioning itself as a key player in the field of mitochondrial medicine.

Laverock Therapeutics is focused on advancing a gene silencing platform that facilitates the development of programmable, allogeneic cell therapies. This innovative platform allows for the engineering of next-generation cell therapies that are both adaptive and capable of responding to various intra- and extra-cellular environmental cues. By enhancing the functionality of these therapies, Laverock Therapeutics aims to improve the efficacy, safety, and accessibility of iPSC-derived products, addressing significant limitations associated with current therapeutic approaches. The company's work is positioned to benefit medical and biotechnology institutions seeking to leverage advanced cell therapy solutions.

Pencil Biosciences is focused on advancing gene-editing technology through the development of a novel, programmable genome-modulation platform. This innovative approach seeks to address the limitations of existing gene-editing technologies, providing new therapeutic options for patients with rare diseases. By enhancing the precision and efficacy of genome modulation, Pencil Biosciences aims to facilitate a wide range of applications in the medical field, ultimately supporting healthcare professionals in overcoming the challenges associated with traditional gene-editing methods.

Laverock Therapeutics is focused on advancing a gene silencing platform that facilitates the development of programmable, allogeneic cell therapies. This innovative platform allows for the engineering of next-generation cell therapies that are both adaptive and capable of responding to various intra- and extra-cellular environmental cues. By enhancing the functionality of these therapies, Laverock Therapeutics aims to improve the efficacy, safety, and accessibility of iPSC-derived products, addressing significant limitations associated with current therapeutic approaches. The company's work is positioned to benefit medical and biotechnology institutions seeking to leverage advanced cell therapy solutions.

Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

NK:IO is a biotechnology company focused on developing natural killer cell-mediated immunotherapies for cancer. The company develops both cell therapies and small molecule therapeutics designed to target cancer and enhance the tumor-killing activity of natural killer cells.

Resurrect Bio is a plant biotechnology company focused on enhancing the immune systems of various crop species. By leveraging innovative resistance genes, the company aims to combat plant diseases effectively, ultimately assisting farmers in cultivating healthier crops. Its mission is to revolutionize the agricultural industry by improving crop resilience, promoting sustainable farming practices, and ensuring greater food security. Through its advancements in biotechnology, Resurrect Bio seeks to address critical challenges faced by farmers and contribute to the overall improvement of agricultural productivity.

HydRegen is a biotechnology company focused on sustainable solutions for chemical manufacturing. It develops bio-based manufacturing technologies and uses biocatalysis to enable the production of clean, safe, and sustainable chemicals. Founded in 2020 and based in Oxford, United Kingdom, the company supports early-stage industrial research and development with greater agility, speed, and predictability. By applying biocatalysis at scale, HydRegen aims to help chemicals and pharmaceutical sectors validate critical cost, productivity, and reproducibility targets, facilitating large-scale deployment of sustainable processes.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Silicon Microgravity is a Cambridge, United Kingdom based sensor technology company that develops microelectromechanical systems for oil and gas reservoir surveillance and other applications. Its gravity sensors deliver high-sensitivity gravity data and ultra-low-frequency seismic data from boreholes, enabling precise density measurements deep in reservoirs and real-time reservoir management. The technology originated as a Cambridge University spin-out, developed with support from BP and Innovate UK, and has broader uses in navigation and stabilization of intelligent systems across commercial, industrial, and military sectors. The company aims to improve efficiency, reduce costs, and support safety and environmental goals in hydrocarbon production.

Solasta Bio develops environmentally friendly biological pesticides and insect control products. Its portfolio includes neuropeptide-based solutions that effectively manage resistant pests, enabling farmers to enhance crop production sustainably.

Productive Machines is a company that specializes in software optimization services for the machining industry, focusing on enhancing productivity and sustainability for manufacturers. By leveraging a digital twin of the machining process, which simulates the physics, mechanics, dynamics, distortion, and vibration involved in metal cutting, Productive Machines enables manufacturers to test millions of parameters in a virtual environment. This innovative approach allows for improved Computer-Aided Manufacturing (CAM) and Gcode, effectively eliminating chatter vibrations, reducing cycle times, minimizing tooling costs, and enhancing surface finish and dimensional accuracy. As a spin-out from the UK Advanced Manufacturing Research Centre, Productive Machines aims to streamline machining processes, empowering companies to achieve higher quality parts more efficiently and cost-effectively.

Sugarox specializes in the development of biostimulants that support farmers in enhancing agricultural productivity and resilience. The company's products are designed to optimize the output of each unit of land while improving the ability of crop systems to withstand challenging weather conditions, such as drought. By focusing on increasing productivity, profitability, efficiency, and sustainability, Sugarox aims to empower farmers to achieve better results in their crop production efforts.

Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

Silveray is a company focused on developing affordable large-area direct conversion detectors specifically for the X-ray imaging market. It leverages advanced core technology that delivers high-performance X-ray imaging through the use of nanoparticle-based X-ray conversion materials. These materials are produced as a semiconductor ink, which is then deposited onto a pixel backplane. This innovative approach enables healthcare providers and various industries to generate an electrical current response to detected X-ray photons, all while maintaining a sustainable cost point. Silveray aims to enhance the efficiency and accessibility of X-ray imaging solutions.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, founded in 2015 as a spin‑out from the STFC Rutherford Appleton Laboratory. It develops high‑performance gas‑sensing products that use laser dispersion, tunable laser absorption, and isotope‑ratio techniques to provide real‑time, in‑situ monitoring of trace gases and isotopologues. The instruments are applied in space exploration, planetary landers, environmental monitoring, atmospheric emissions, geochemistry, medical diagnostics, and oil‑and‑gas exploration and production. The company’s cloud‑connected platform delivers autonomous, continuous measurements in all weather conditions, enabling detection, localisation, and quantification of emissions to support net‑zero targets and operational optimisation.

Lineat is a manufacturer specializing in fiber tape products, particularly focusing on carbon fiber tapes produced through aligned formable fiber technology. This innovative approach allows for the creation of aligned discontinuous fiber tapes that demonstrate mechanical performance comparable to traditional continuous fiber composites. By simplifying the composite manufacturing process, Lineat enhances formability and streamlines both manual and automated operations. Additionally, the company has implemented a closed-loop water circulation system aimed at improving lifecycle assessment (LCA), reflecting its commitment to sustainability in production practices.

MitoRx Therapeutics is a biotechnology company focused on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company specializes in creating mitochondrial-protective treatments for a range of conditions, including neuromuscular disorders, metabolic diseases, and dementia. By targeting the underlying mitochondrial issues associated with these challenging diseases, MitoRx Therapeutics seeks to enable healthcare professionals to halt the progression of conditions such as dystrophy and neurodegeneration. In addition to its internal research on rare indications, the company also collaborates on broader health issues, positioning itself as a key player in the field of mitochondrial medicine.

Q5D is an innovative company specializing in the automation of manufacturing and assembly processes for wiring looms. It develops advanced tools and laser micromachining technology that streamline the intricate connections of electric components. Q5D's solutions cater to various industrial sectors, including automotive, aerospace, consumer electronics, and robotics. By enabling the direct addition of wire and printed electronics onto product surfaces, the company enhances manufacturing quality, productivity, and functionality while simultaneously lowering production costs. This technology provides clients with a competitive advantage in achieving efficiency, resilience, and sustainability in their operations.

Atheras Analytics is a developer of AI-based software tools tailored for the design and operation of Ka-band and Q/V-band satellite networks. The company focuses on mitigating weather-related impacts and enhancing network and service availability. Utilizing advanced machine-learning algorithms, Atheras Analytics leverages a comprehensive database of satellite signal propagation time-series measurements and high-resolution data. This innovative approach enables satellite operators to optimize the design of multi-gateway satellite networks, ultimately facilitating more cost-effective solutions in the industry.

Solasta Bio develops environmentally friendly biological pesticides and insect control products. Its portfolio includes neuropeptide-based solutions that effectively manage resistant pests, enabling farmers to enhance crop production sustainably.

NanoSyrinx is a biotechnology company focused on developing a novel biologics drug delivery platform that targets therapeutic proteins and peptides to the cytosol of cells. Through synthetic biology, the company seeks to transport payloads directly into cell interiors, aiming to improve the efficacy, safety, and cost-effectiveness of treatments. The platform is designed to serve the biopharmaceutical sector by enabling targeted delivery of biologics to intracellular targets, with potential to enhance treatment outcomes across multiple indications.

AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Antiverse is an innovative biotechnology company specializing in accelerating drug development through its proprietary platform. This platform combines structural biology, machine learning, and medicine to facilitate quicker and more cost-effective breakthroughs in antibody discovery.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Solasta Bio develops environmentally friendly biological pesticides and insect control products. Its portfolio includes neuropeptide-based solutions that effectively manage resistant pests, enabling farmers to enhance crop production sustainably.

NanoSyrinx is a biotechnology company focused on developing a novel biologics drug delivery platform that targets therapeutic proteins and peptides to the cytosol of cells. Through synthetic biology, the company seeks to transport payloads directly into cell interiors, aiming to improve the efficacy, safety, and cost-effectiveness of treatments. The platform is designed to serve the biopharmaceutical sector by enabling targeted delivery of biologics to intracellular targets, with potential to enhance treatment outcomes across multiple indications.

Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

MicrofluidX Ltd is a London-based company established in 2018 that specializes in developing a cell bioprocessing platform specifically designed for autologous cell and gene therapy manufacturing. The company offers a microfluidic bioprocessing system that integrates various cell culture capabilities—including seeding, expansion, differentiation, transduction, washing, sorting, concentration, sampling, and harvesting—into a single closed system. This automated technology addresses key challenges in the field, such as process control, scalability, and cost, enabling biologists to efficiently conduct process development by experimenting with multiple cell culture conditions.

Ikarovec is a gene therapy company focused on developing early-stage treatments for common eye diseases, particularly diabetic macular edema. The company aims to address multiple disease targets and pathways, working on therapies that also target dry-form age-related macular degeneration, neovascular (wet-form) age-related macular degeneration, and ocular hypertension. By advancing these innovative treatments, Ikarovec seeks to provide effective solutions for patients, helping to restore sight and prevent blindness.

Pencil Biosciences is focused on advancing gene-editing technology through the development of a novel, programmable genome-modulation platform. This innovative approach seeks to address the limitations of existing gene-editing technologies, providing new therapeutic options for patients with rare diseases. By enhancing the precision and efficacy of genome modulation, Pencil Biosciences aims to facilitate a wide range of applications in the medical field, ultimately supporting healthcare professionals in overcoming the challenges associated with traditional gene-editing methods.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Founded to address Needle Stick Injuries (NSIs) in healthcare settings, C-Major Medical develops safety devices aimed at reducing NSIs and contaminating aerosols. Their innovative syringe and blood collection system enhances staff safety and enables hospitals, clinics, and practitioners worldwide to prevent such injuries.

Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Procarta Biosystems Ltd is a biotechnology company based in Norwich, United Kingdom, that specializes in the development of innovative DNA-based antibacterials. Founded in 2007 as a spin-out from the John Innes Centre, Procarta focuses on addressing the critical challenge of drug-resistant bacterial strains, commonly referred to as superbugs. The company has created a versatile platform for antibiotic development, which includes proprietary nanoparticles designed to deliver oligonucleotides directly into bacterial pathogens. Their product range features targeted therapies such as MRSA snare, a solution for both topical and intravenous use; Broad-spectrum Gram-negative therapy snare, aimed at treating hospital-acquired infections; and Cdiff snare, which helps prevent the recurrence of Clostridium difficile infections. With a commitment to combating the rising threat of antibiotic resistance, Procarta Biosystems is positioned to enhance therapeutic options in clinical settings.

Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

Antiverse is an innovative biotechnology company specializing in accelerating drug development through its proprietary platform. This platform combines structural biology, machine learning, and medicine to facilitate quicker and more cost-effective breakthroughs in antibody discovery.

Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Glialign is focused on advancing innovative cell therapies aimed at repairing peripheral nerves, a critical area where existing treatments often fall short, achieving success in less than half of cases. The company has developed regenerative technologies that facilitate surgeries involving living neural tissue. Its primary product is a living nerve growth guide designed for peripheral nerve repair, serving as an effective, off-the-shelf alternative to traditional nerve allografts. This technology eliminates the need for a secondary surgical procedure to harvest nerves from other body parts, thereby streamlining the treatment process. By enabling healthcare providers to guide nerve regeneration, Glialign aims to enhance recovery outcomes for patients suffering from nerve injuries.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, founded in 2015 as a spin‑out from the STFC Rutherford Appleton Laboratory. It develops high‑performance gas‑sensing products that use laser dispersion, tunable laser absorption, and isotope‑ratio techniques to provide real‑time, in‑situ monitoring of trace gases and isotopologues. The instruments are applied in space exploration, planetary landers, environmental monitoring, atmospheric emissions, geochemistry, medical diagnostics, and oil‑and‑gas exploration and production. The company’s cloud‑connected platform delivers autonomous, continuous measurements in all weather conditions, enabling detection, localisation, and quantification of emissions to support net‑zero targets and operational optimisation.

Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

Atelerix Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2006. It specializes in the storage and transportation of cells and tissues at room temperature, utilizing a patented technology that encapsulates biological products in a natural hydrogel. This innovative approach allows for the safe shipment and storage of viable cells, including suspended cells, planted cells, and stem cells, without the need for cryopreservation or harmful supplements. By protecting cells from biochemical and physical damage, Atelerix enables immediate use of cells and assays upon arrival, enhancing reliability in drug discovery and cell therapy applications. The company's technology contributes to more predictable and effective outcomes in medical and research settings.

Procarta Biosystems Ltd is a biotechnology company based in Norwich, United Kingdom, that specializes in the development of innovative DNA-based antibacterials. Founded in 2007 as a spin-out from the John Innes Centre, Procarta focuses on addressing the critical challenge of drug-resistant bacterial strains, commonly referred to as superbugs. The company has created a versatile platform for antibiotic development, which includes proprietary nanoparticles designed to deliver oligonucleotides directly into bacterial pathogens. Their product range features targeted therapies such as MRSA snare, a solution for both topical and intravenous use; Broad-spectrum Gram-negative therapy snare, aimed at treating hospital-acquired infections; and Cdiff snare, which helps prevent the recurrence of Clostridium difficile infections. With a commitment to combating the rising threat of antibiotic resistance, Procarta Biosystems is positioned to enhance therapeutic options in clinical settings.

SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

Founded to address Needle Stick Injuries (NSIs) in healthcare settings, C-Major Medical develops safety devices aimed at reducing NSIs and contaminating aerosols. Their innovative syringe and blood collection system enhances staff safety and enables hospitals, clinics, and practitioners worldwide to prevent such injuries.

MyoDOPA is develops a novel therapeutic profile providing efficient treatment.

Camstech is an early-stage company developing novel biochemical sensing technologies for life sciences research, biotechnology, and medical diagnostics. Founded in 2014 around a sensing technology from Professor Pankaj Vadgama, the company commercializes electrochemical sensor platforms and novel electrodes with improved stability and resistance to biofouling, enabling continuous monitoring and the development of tests for new biomarkers. It originated from the CERN Business Incubation Centre at Harwell and is based at STFC's Campus Technology Hub at Daresbury Laboratory, with a focus on point-of-care diagnostics.

Cagen is a synthetic biology company.

Pireta Ltd, established in 2017 and headquartered in Teddington, UK, specializes in developing and commercializing smart textile technology. The company's core business involves creating an additive process that imparts conductivity and sensors to fabrics at any stage of manufacturing, without altering their handle or drape. Pireta's innovative textiles are used across various industries, including military and defense, healthcare, fashion, athletics, and RFID tagging, enabling communication, physiological measurement tracking, and electronic system integration on a wide range of fabrics.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Puraffinity specializes in designing and developing precision materials for water treatment. Founded in 2015 and based in London, it has pioneered a sustainable novel adsorbent capable of removing challenging pollutants from contaminated water and wastewater. Utilizing advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals to functionalized sustainable materials, addressing imminent water quality challenges while promoting positive environmental impact.

Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.

Tropic Biosciences UK Ltd, established in 2016 and based in Norwich, is a biotechnology company specializing in the development of commercial tropical crops. It employs advanced plant breeding and non-GMO gene editing techniques to create high-performing varieties, catering primarily to the coffee and banana industries. The company's mission is to promote grower wellbeing, consumer health, and sustainable environmental practices through its innovative, non-GMO methods, which significantly accelerate the breeding process to meet growing food demands and local community needs.

Linear Diagnostics Limited is a diagnostic technology company based in Birmingham, United Kingdom, founded in 2011. The company specializes in developing a novel diagnostic platform that utilizes linear dichroism (LD) to perform a wide range of molecular diagnostics tests. This technology allows for the rapid detection of multiple targets from a single sample, providing significant advantages over conventional methods. Linear Diagnostics focuses on various applications, including the detection of antibiotic resistance in infections and identifying bacteria responsible for food crop spoilage. Additionally, the company offers a handheld reader designed for measuring LD signals, enhancing the accessibility and efficiency of its diagnostic solutions. By addressing limitations associated with traditional detection techniques, Linear Diagnostics aims to improve healthcare outcomes and reduce costs.

Nemesis Bioscience Ltd., established in 2014 and headquartered in Cambridge, UK, specializes in developing and commercializing innovative therapeutic agents. The company's core focus is to restore the effectiveness of existing antibiotics against currently resistant microbial pathogens. Nemesis Bioscience achieves this through its symbiotics, which directly kill pathogenic microorganisms and/or sensitize them to currently available antibiotics. The company's solutions are employed to treat infections and prevent patients from acquiring potentially life-threatening resistant pathogens. Nemesis Bioscience has been recognized for its work, having received the King's College, Cambridge Entrepreneurship Award in 2014, and has filed international patent applications for its inventions.

Founded in 2008, The Electrospinning Company specializes in designing, developing, and manufacturing biomaterials for regenerative medical devices and 3D cell culture products. Its primary offerings include aligned fiber scaffolds, plates with removable scaffold discs, and tissue culture plates with hanging inserts, catering to applications in tissue engineering, regenerative medicine, and drug discovery research.

AgPlus Diagnostics Ltd. is a UK-based company specializing in the development of diagnostic platform technology aimed at providing quantitative point-of-care (PoC) testing solutions for various clinical applications, including both human and veterinary diagnostics. Founded in 2009 and headquartered in Sharnbrook, the company designs, manufactures, and supplies diagnostic tests and associated readers. AgPlus Diagnostics focuses on creating portable diagnostic devices that utilize electrochemical signaling and measurement systems, enabling healthcare providers to deliver personalized care through rapid and accurate testing. This innovative approach facilitates timely diagnostic results, allowing healthcare professionals to make critical treatment decisions quickly, ultimately benefiting patient outcomes.

Keit Ltd. is a company specializing in the design and manufacture of advanced spectrometers and related instruments, catering to a wide range of applications from ultraviolet to far infrared rays. Incorporated in 2012 and headquartered in Didcot, United Kingdom, Keit is known for its innovative microFTS® design, a Fourier Transform Infrared (FTIR) spectrometer that is notably smaller, lighter, and more rugged than existing systems. Originally developed for space applications, the microFTS® is capable of operating in extreme environments and sets a new standard for real-time liquid-state analyses across various industries, including Pharmaceutical, Chemical, Oil & Gas, and Food & Beverage. Keit's products are also utilized for measuring signal levels, near line vibrations, and analyzing gas or liquid-borne species.

MIRICO Ltd. is a laser spectroscopy instrumentation company based in Oxford, founded in 2015 as a spin‑out from the STFC Rutherford Appleton Laboratory. It develops high‑performance gas‑sensing products that use laser dispersion, tunable laser absorption, and isotope‑ratio techniques to provide real‑time, in‑situ monitoring of trace gases and isotopologues. The instruments are applied in space exploration, planetary landers, environmental monitoring, atmospheric emissions, geochemistry, medical diagnostics, and oil‑and‑gas exploration and production. The company’s cloud‑connected platform delivers autonomous, continuous measurements in all weather conditions, enabling detection, localisation, and quantification of emissions to support net‑zero targets and operational optimisation.

Jupiter Diagnostics is a company that specializes in innovative blood testing solutions utilizing patented nano crystal labeled technology. This technology allows for the rapid processing of multiple blood tests from a simple finger prick, delivering results within 10 minutes and at a cost significantly lower than traditional laboratory testing. By providing high-quality and affordable diagnostics, Jupiter Diagnostics aims to enhance the accessibility of medical testing for both clinicians and patients. Their intuitive testing process simplifies blood sample collection, facilitating quicker decision-making for healthcare practitioners and ultimately improving patient care.

Quethera Limited is a biotechnology company based in Canterbury, United Kingdom, focused on developing gene therapy treatments for glaucoma and other ophthalmic diseases. Established in 2013, the company aims to address progressive visual loss associated with these conditions, particularly in patients experiencing accelerated deterioration of their visual fields. Quethera collaborates with leading experts in the field of glaucoma to design and conduct clinical trials that assess the efficacy and safety of its innovative therapies. With a strong foundation in gene therapeutic design and development, Quethera is advancing its pipeline from preclinical testing into clinical development, striving to provide effective treatment solutions for common blinding eye diseases. As of 2018, Quethera operates as a subsidiary of Astellas Pharma Inc.

Oxford Space Systems Limited is a Harwell, United Kingdom-based company that specializes in the development and manufacturing of deployable hardware structures for space environments. Founded in 2013, the company has gained recognition for its innovative designs, including deployable antennas, panels, hinge systems, and composite linear boom systems. Utilizing advanced techniques such as origami and proprietary materials, Oxford Space Systems creates solutions that are lighter, more efficient, and cost-effective compared to traditional alternatives, catering to the global satellite industry. The company's AstroTube Boom set a record for the fastest product development from concept to successful deployment in under 30 months. With a team of 18 professionals, combining diverse backgrounds and over a century of collective experience in the space sector, Oxford Space Systems has engaged in various collaborative projects with leading European satellite manufacturers and has secured commercial contracts across Asia and the US. The company operates from a state-of-the-art facility within the Harwell Space Cluster, equipped to meet the security requirements necessary for defense and security contracts.

Perfectus Biomed is a microbiological services provider that focuses on delivering customized and research-based microbiological testing solutions. The company specializes in bespoke assays, particularly in the area of biofilm testing, recognizing the unique needs of each client and the limitations of standard testing methods. By collaborating closely with clients, Perfectus Biomed develops tailored methods suitable for testing novel products, ensuring a high level of service that includes regular feedback, consultancy, and comprehensive report writing. The company's platform is designed to offer both standard and customized microbiology testing services, emphasizing timely and efficient operations while maintaining an academic approach to contract microbiological testing. Additionally, Perfectus Biomed produces conference abstracts and posters based on the data generated from its testing services.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

NorthRow is a digital platform that aids businesses in streamlining risk management, compliance, and fraud prevention processes. It offers standalone or combined features such as detailed checks on individuals, companies, and documents to optimize business operations, mitigate risks, and ensure regulatory compliance.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Spectral Edge Ltd, established in 2011 and headquartered in Cambridge, UK, specializes in image enhancement technologies. The company develops innovative solutions such as Phusion, which improves image and video quality by leveraging information outside the visible spectrum, and Eyeteq, a video personalization technology that enhances TV accessibility for color-blind individuals. Spectral Edge's products cater to consumer electronics manufacturers and service providers, serving applications like computational photography, security, and consumer electronics. As of 2019, the company operates as a subsidiary of Apple Inc.

Tokamak Energy Ltd is a private company based in Abingdon, United Kingdom, focused on the development of fusion power technology. Founded in 2009, the company specializes in creating compact and cost-effective fusion power devices, particularly through the use of spherical tokamaks. These innovative reactors are designed to achieve higher plasma pressure with reduced magnetic field requirements compared to traditional tokamaks. Tokamak Energy utilizes high-temperature superconducting magnets to enhance plasma control within its devices, thereby improving efficiency. The company's commitment to rapid innovation leverages advanced materials and technology, building on decades of scientific research. By aiming to develop commercial fusion power solutions, Tokamak Energy contributes to the pursuit of affordable and sustainable energy, addressing global energy security while minimizing environmental impact.

Claresys Ltd. is a company that specializes in the development and supply of lens solutions specifically designed for covert surveillance applications. Its product range includes covert pinhole pan/tilt/zoom lenses suitable for C mount 1/3” sensor cameras, as well as miniature pinhole camera lenses. Claresys also offers custom lens designs tailored for long-range surveillance in challenging environments, such as nuclear and high-temperature fields. The company's optical technologies are utilized in various surveillance contexts, allowing for effective close surveillance in buildings and vehicles, as well as long-distance stake-outs. Primarily serving customers in the defense, homeland security, and police sectors, Claresys markets its products through a network of distributors across several countries, including the United Kingdom, the United States, Australia, and various European nations. Established in 2007 and headquartered in Abingdon, United Kingdom, Claresys aims to provide high-performance optical solutions that enhance both the effectiveness and safety of surveillance operations.

NorthRow is a digital platform that aids businesses in streamlining risk management, compliance, and fraud prevention processes. It offers standalone or combined features such as detailed checks on individuals, companies, and documents to optimize business operations, mitigate risks, and ensure regulatory compliance.

Eagle Genomics is a life sciences software company that provides data management and analytics platforms for genomics and related fields. Its solutions enable management, orchestration and exploitation of genomics and other life sciences data, turning diverse datasets into usable data assets and supporting end-to-end workflows from data integration and curation to analysis, visualization and sharing. The company combines biology, bioinformatics, data science, and enterprise software engineering to help pharmaceutical, consumer goods, and agricultural technology organizations shorten research cycles and improve decision making. Its offerings cover next-generation sequencing data management and analysis, cloud-based bioinformatics, biomarker discovery, microarray analysis, and pipeline design, as well as on-demand consulting and tools for managing research data. Headquartered in Cambridge, United Kingdom, with an international footprint, Eagle Genomics emphasizes building an enterprise information architecture for the genomics era, enabling customers to realize the value of digital assets and enhance productivity across R&D programs.

Desktop Genetics is an international biotechnology company to helps researchers discover and treat the root genetic causes of human disease. Desktop Genetics is a recognized leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians, and data scientists. The company's tools and technologies are used by organizations all over the world. It enables the work of their pharma, biotech, and academic customers working in drug discovery and functional genomics.

CellCentric Ltd. is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer therapeutics. Established in 2003, the company specializes in small-molecule inhibitors targeting p300, CBP, and specific deubiquitinase enzymes, which play a crucial role in regulating gene expression in cancer cells. Its primary research program addresses prostate cancer, a significant cause of male mortality, by modulating the androgen receptor pathway and potentially overcoming resistance mechanisms found in existing treatments. Additionally, CellCentric's products have applications in treating other cancers, including non-small cell lung cancer, breast cancer, and colon cancer. The company's approach aims to provide targeted therapies for various malignancies, addressing unmet medical needs in the oncology field.

Perfectus Biomed is a microbiological services provider that focuses on delivering customized and research-based microbiological testing solutions. The company specializes in bespoke assays, particularly in the area of biofilm testing, recognizing the unique needs of each client and the limitations of standard testing methods. By collaborating closely with clients, Perfectus Biomed develops tailored methods suitable for testing novel products, ensuring a high level of service that includes regular feedback, consultancy, and comprehensive report writing. The company's platform is designed to offer both standard and customized microbiology testing services, emphasizing timely and efficient operations while maintaining an academic approach to contract microbiological testing. Additionally, Perfectus Biomed produces conference abstracts and posters based on the data generated from its testing services.

SFH Oxford Ltd. is a UK-based company specializing in the development and marketing of innovative healthcare products aimed at enhancing the management of venous leg ulcers. Founded in 2011 and located in Didcot, the company has created Graducheck, a sensor-based technology that improves the application of compression bandages, thereby increasing healing rates and promoting patient compliance. SFH Oxford also offers anatomic focus technology graduated compression socks, which provide essential graduated compression, and K-gel wound dressings. The company is actively engaged in clinical and field trials for several of its products, which are showing promising results in real-world applications. With a leadership team experienced in medical device technology, wound care, and business development, SFH Oxford is focused on delivering optimized care for patients and healthcare professionals involved in ulcer management.

Tokamak Solutions UK Ltd. engages in providing technology for fusion neutron source to transmute nuclear waste. The company was founded in 2009 and is based in Abingdon, United Kingdom.